# Roche has signed a deal to pay $750 million upfront for Boston-based PathAI.

*biotech · news · 2026-05-07 · The Boston Globe*

## Key points

- Roche will acquire PathAI for $750 million upfront, with up to $300 million in milestones.
- The acquisition is expected to close in the second half of this year.
- PathAI's AI-powered pathology tools will be integrated with Roche's oncology diagnosis platforms.
- This deal follows an initial 2021 Roche-PathAI partnership later expanded to AI companion diagnostics.

**Companies:** Roche, PathAI
**Countries:** Switzerland, United States

[Read the full story on The Boston Globe](https://www.bostonglobe.com/2026/05/07/business/roche-pathai-acquisition-pathology/)

---

Canonical: https://newsio.io/n/74dc1c58-22c6-4172-9919-5164feb6ae84/roche-has-signed-a-deal-to-pay-750-million-upfront-for-boston-based-pathai-the-a
Summarized by Newsio from The Boston Globe. https://newsio.io/how-it-works